249 related articles for article (PubMed ID: 9431831)
21. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
[TBL] [Abstract][Full Text] [Related]
22. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
23. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
[TBL] [Abstract][Full Text] [Related]
24. Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen X; Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
Drug Metab Dispos; 2001 Nov; 29(11):1359-61. PubMed ID: 11602509
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant.
Sanchez RI; Wang RW; Newton DJ; Bakhtiar R; Lu P; Chiu SH; Evans DC; Huskey SE
Drug Metab Dispos; 2004 Nov; 32(11):1287-92. PubMed ID: 15304427
[TBL] [Abstract][Full Text] [Related]
26. The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.
Ring BJ; Gillespie JS; Binkley SN; Campanale KM; Wrighton SA
Drug Metab Dispos; 2002 Sep; 30(9):957-61. PubMed ID: 12167559
[TBL] [Abstract][Full Text] [Related]
27. Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide.
Zhang L; Fitzloff JF; Engel LC; Cook CS
Xenobiotica; 2001 Feb; 31(2):73-83. PubMed ID: 11407536
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes.
Bachmann K; He Y; Sarver JG; Peng N
Xenobiotica; 2003 Mar; 33(3):265-76. PubMed ID: 12637244
[TBL] [Abstract][Full Text] [Related]
29. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
[TBL] [Abstract][Full Text] [Related]
30. Application of substrate depletion assay to evaluation of CYP isoforms responsible for stereoselective metabolism of carvedilol.
Iwaki M; Niwa T; Bandoh S; Itoh M; Hirose H; Kawase A; Komura H
Drug Metab Pharmacokinet; 2016 Dec; 31(6):425-432. PubMed ID: 27836712
[TBL] [Abstract][Full Text] [Related]
31. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.
Albassam AA; Ahad A; Alsultan A; Al-Jenoobi FI
Saudi Pharm J; 2018 Jul; 26(5):673-677. PubMed ID: 29989011
[TBL] [Abstract][Full Text] [Related]
33. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
Desta Z; Wu GM; Morocho AM; Flockhart DA
Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
[TBL] [Abstract][Full Text] [Related]
34. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
35. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
[TBL] [Abstract][Full Text] [Related]
36. Nefiracetam metabolism by human liver microsomes: role of cytochrome P450 3A4 and cytochrome P450 1A2 in 5-hydroxynefiracetam formation.
Fujimaki Y; Arai N; Nakazawa T; Fujimaki M
J Pharm Pharmacol; 2001 Jun; 53(6):795-804. PubMed ID: 11428655
[TBL] [Abstract][Full Text] [Related]
37. Differences in cytochrome P450 forms involved in the metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a novel sigma ligand, in human liver and intestine.
Yamamoto T; Hagima N; Nakamura M; Kohno Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2003 Jan; 31(1):60-6. PubMed ID: 12485954
[TBL] [Abstract][Full Text] [Related]
38. Multiple cytochrome P450 enzymes responsible for the oxidative metabolism of the substituted (S)-3-phenylpiperidine, (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, in human liver microsomes.
Wienkers LC; Wynalda MA
Drug Metab Dispos; 2002 Dec; 30(12):1372-7. PubMed ID: 12433806
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
[TBL] [Abstract][Full Text] [Related]
40. Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro.
Zhang W; Ramamoorthy Y; Tyndale RF; Sellers EM
Drug Metab Dispos; 2003 Jun; 31(6):768-72. PubMed ID: 12756210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
